Docusign (NASDAQ:DOCU – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.06, FiscalAI reports. The company had revenue of $836.86 million during the quarter, compared to analysts’ expectations of $828.23 million. Docusign had a net margin of 9.57% and a return on equity of 15.02%. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 EPS.
Docusign Stock Up 1.5%
Shares of NASDAQ DOCU traded up $0.72 during trading hours on Tuesday, hitting $47.54. 7,859,945 shares of the stock were exchanged, compared to its average volume of 4,804,390. Docusign has a 12 month low of $40.16 and a 12 month high of $94.67. The firm has a fifty day moving average price of $51.11 and a 200-day moving average price of $64.46. The company has a market cap of $9.52 billion, a PE ratio of 33.24, a PEG ratio of 2.05 and a beta of 1.03.
Insiders Place Their Bets
In other Docusign news, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $67.05, for a total value of $402,300.00. Following the completion of the sale, the executive owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $67.03, for a total value of $804,360.00. Following the sale, the insider owned 54,550 shares in the company, valued at $3,656,486.50. The trade was a 18.03% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 74,810 shares of company stock valued at $5,115,951. 1.66% of the stock is currently owned by company insiders.
Institutional Trading of Docusign
Analyst Ratings Changes
Several research analysts recently issued reports on the company. Evercore dropped their price objective on Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a research note on Friday, December 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research report on Tuesday, March 10th. Cantor Fitzgerald reiterated an “outperform” rating on shares of Docusign in a report on Wednesday, December 17th. HSBC set a $53.00 price target on Docusign in a research report on Friday, February 13th. Finally, Wells Fargo & Company decreased their price objective on Docusign from $85.00 to $75.00 and set an “equal weight” rating for the company in a report on Friday, December 5th. Five analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $78.80.
Get Our Latest Analysis on DOCU
Trending Headlines about Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Q4 earnings and revenue beat consensus (EPS $1.01 vs. $0.95 estimate), showing upside to recent expectations — this is the primary near?term catalyst supporting the stock. DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
- Positive Sentiment: Company raised its share buyback authorization by $2.0 billion — a direct capital?allocation move that supports EPS and can buoy the stock. Docusign Announces Fourth Quarter and Fiscal Year 2026 Financial Results; Announces $2.0 Billion Increase to Share Repurchase Program
- Positive Sentiment: Board addition of an AI?focused independent director and ongoing AI product integrations are being viewed as strategic positives that could drive future subscription expansion beyond e?signatures. The Bull Case For DocuSign (DOCU) Could Change Following New AI-Focused Director Appointment – Learn Why
- Neutral Sentiment: Analysts and previews focused on key Q4 metrics and guidance comparisons; these items will matter for next?quarter sentiment but are read as routine post?earnings analysis. DocuSign (DOCU) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Neutral Sentiment: Marketwide drivers (Fed/FOMC meeting, macro data, big?tech events) are creating broader volatility that could amplify DOCU moves short?term. Markets Wait for Fed’s FOMC Meeting
- Negative Sentiment: Bearish commentary warns DOCU remains vulnerable after a steep multi?month pullback; some analysts flag valuation and downside risk if execution or guidance disappoints. DocuSign stock price at risk of a steep crash after earnings on March 17
Docusign Company Profile
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Further Reading
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
